|
Name |
ent-blennolide J
|
Molecular Formula | C32H30O14 | |
IUPAC Name* |
methyl1,4,8-trihydroxy-7-[5-hydroxy-2-methoxycarbonyl-2-(3-methyl-5-oxooxolan-2-yl)-4-oxo-3H-chromen-6-yl]-3-methyl-9-oxo-3,4-dihydro-2H-xanthene-4a-carboxylate
|
|
SMILES |
COC(=O)C1(C2OC(=O)CC2C)CC(=O)c2c(ccc(-c3ccc4c(c3O)C(=O)C3=C(O)CC(C)C(O)C3(C(=O)OC)O4)c2O)O1
|
|
InChI |
InChI=1S/C32H30O14/c1-12-9-16(33)23-26(38)22-19(46-32(23,27(12)39)30(41)43-4)8-6-15(25(22)37)14-5-7-18-21(24(14)36)17(34)11-31(45-18,29(40)42-3)28-13(2)10-20(35)44-28/h5-8,12-13,27-28,33,36-37,39H,9-11H2,1-4H3/t12-,13+,27+,28+,31+,32+/m0/s1
|
|
InChIKey |
MLEYBVBRIZGXRW-VXMMYZNKSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 638.58 | ALogp: | 2.3 |
HBD: | 4 | HBA: | 14 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 212.4 | Aromatic Rings: | 6 |
Heavy Atoms: | 46 | QED Weighted: | 0.28 |
Caco-2 Permeability: | -5.399 | MDCK Permeability: | 0.00001630 |
Pgp-inhibitor: | 0.897 | Pgp-substrate: | 0.2 |
Human Intestinal Absorption (HIA): | 0.796 | 20% Bioavailability (F20%): | 0.014 |
30% Bioavailability (F30%): | 0.923 |
Blood-Brain-Barrier Penetration (BBB): | 0.012 | Plasma Protein Binding (PPB): | 89.08% |
Volume Distribution (VD): | 0.499 | Fu: | 4.12% |
CYP1A2-inhibitor: | 0.018 | CYP1A2-substrate: | 0.635 |
CYP2C19-inhibitor: | 0.035 | CYP2C19-substrate: | 0.121 |
CYP2C9-inhibitor: | 0.099 | CYP2C9-substrate: | 0.595 |
CYP2D6-inhibitor: | 0.026 | CYP2D6-substrate: | 0.192 |
CYP3A4-inhibitor: | 0.844 | CYP3A4-substrate: | 0.493 |
Clearance (CL): | 12.045 | Half-life (T1/2): | 0.021 |
hERG Blockers: | 0.018 | Human Hepatotoxicity (H-HT): | 0.863 |
Drug-inuced Liver Injury (DILI): | 0.969 | AMES Toxicity: | 0.016 |
Rat Oral Acute Toxicity: | 0.982 | Maximum Recommended Daily Dose: | 0.038 |
Skin Sensitization: | 0.018 | Carcinogencity: | 0.068 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.007 |
Respiratory Toxicity: | 0.017 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003348 | 0.799 | D01XWG | 0.303 | ||||
ENC005733 | 0.719 | D01XDL | 0.297 | ||||
ENC005734 | 0.669 | D0T5XN | 0.292 | ||||
ENC000983 | 0.649 | D0C9XJ | 0.291 | ||||
ENC000710 | 0.649 | D07VLY | 0.291 | ||||
ENC000954 | 0.649 | D07IPB | 0.277 | ||||
ENC005735 | 0.645 | D01UBX | 0.268 | ||||
ENC005736 | 0.633 | D0T8EH | 0.263 | ||||
ENC003347 | 0.608 | D0FX2Q | 0.246 | ||||
ENC003816 | 0.586 | D0AZ8C | 0.246 |